Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Mielke

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Blood Advances|February 20, 2020
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaRichard T Maziarz, Edmund K Waller, Ulrich Jaeger, et al.
Hemasphere|October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete RemissionMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Journal of Hematology & Oncology|June 26, 2017
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Matthias Stelljes, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Blood Advances|February 20, 2020
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaRichard T Maziarz, Edmund K Waller, Ulrich Jaeger, et al.
Hemasphere|October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete RemissionMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Journal of Hematology & Oncology|June 26, 2017
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Matthias Stelljes, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
Bone Marrow Transplantation|November 12, 2024
Satisfactory outcomes following a second autologous hematopoietic cell transplantation for multiple myeloma in poor stem cell mobilizers: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMatjaz Sever, Joanna Drozd-Sokolowska, Luuk Gras, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Blood|July 24, 2014
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDAhmad Khoder, Anushruti Sarvaria, Abdullah Alsuliman, et al.
Pageof 13